Resources

The Cell and Gene Therapy (CGT) Catapult has published new insights into the advancement of the UK’s cell and gene therapy industry in its Annual Review.

Brainomix announced new data published in the esteemed American Journal of Respiratory & Critical Care Medicine (AJRCCM)

Medicines Discovery Catapult has appointed Dr Mike Strange as its Chief Executive Officer.

Poolbeg Pharma announces its unaudited interim results for the six months to 30 June 2026.

Poolbeg Pharma reaffirmed that participant recruitment for the POLB 001 TOPICAL trial is progressing well. Following the previously announced six-patient safety cohort, a total of eight participants have now been dosed out of c.30, since the first patient dosed in July 2026.

Global drug development consultancy Boyds has strengthened its Regulatory Affairs team with the appointment of two senior specialists.

£135 million for two life sciences funds, rare disease R&D, Beacon Therapeutics, Basecamp Research’s Series C, Birmingham Life Sciences Week, Liberal Democrat party conference, Women in Biotech Edinburgh

To mark World Cancer Research Day, we are proud to share this film celebrating innovation in immunotherapy, the passion of our team working together in scientific discovery and our shared goal of developing new approaches for patients with cancer.

Barry Callebaut, the world’s leading manufacturer of high-quality chocolate and cocoa solutions, has moved into Colworth Science Park’s food tech incubator Gastronomica.

Latest Press Release Announcing Momentum Pharma (BIA member organisation) growth, launching a business in Australia to better serve the Australia and APAC region.

Positive interim review marks key milestone for POLB 001 clinical development

New service brings senior regulatory expertise into the early development window, when strategic decisions can have the greatest impact. DLRC, an award-winning global regulatory and market access consultancy that supports the development and licensing of pharmaceutical, biotech, advanced therapy, and medtech products worldwide, launches Regulatory Spark, a new fixed-fee, fast-turnaround service created for early-stage innovators.

Engitix announced the appointment of Sonia Quaratino, MD, PhD in the newly created role of Executive Vice President (EVP) Chief Medical Officer (CMO).

PACE and the UK Health Security Agency (UKHSA) have released five new contemporary antimicrobial resistance (AMR) strain panels, giving innovators worldwide a resource to test novel therapeutics and diagnostics against today’s resistance patterns

Regional cluster updates, fresh OLS data, NICE's Enhertu approval and £89.9m for Chemify - catch up on this week's CEO blog.

Global drug development consultancy Boyds has reported robust revenue growth for the financial year ending March 2026, despite the slowdown in the global biotech and pharma markets.

Analysis for Innovators (A4I) is a funding programme that helps UK SMEs overcome complex measurement, testing and analysis challenges by providing access to world-class expertise, specialist facilities and scientific knowledge from leading UK measurement organisations, including NML.

Causeway Sensors and Fusion Antibodies share a case study on how TITAN’s real-time, at-line analytics detected key harvest yield differences by Day 3, enabling early process intervention and smarter resource allocation.